CHA Corporate - Cambridge Healthtech Associates

We are a leading consulting firm
within life sciences and
an organizer and facilitator of
consortia and communities
to encourage collaboration
within the industry

BIOPHARMA COMPANIES

We bring together biopharma leaders, senior executives and top scientists to encourage knowledge sharing at the pre-competitive level.

TECHNOLOGY PROVIDERS

We improve marketing ROI by leveraging our robust industry networks and partnerships to provide innovators with valuable feedback and analysis.

Press Releases

OMT Recipient of Signature Award

arGEN-X Recipient of Signature Award

The Case for Investing in Predictive Drug Safety Technologies

In my previous article, Can My Efficacy Screening Test also Be a Drug Screen, I explained the differences between a discovery-stage efficacy test and a drug safety test. Entering the drug safety market requires more effort than breaking into the discovery market.

Leaders dedicated to advancing the development of better and safer medicines.
Visit to learn more

NGSLeaders

Pioneers in advancing the use and value of next-generation sequencing technologies.Visit to learn more